ID.1
Item
diabetes mellitus type 2 diagnosed (baseline glycemia > 7,0 mmol/l (126 mg/dl) or overload glycemia > 11,0 mmol/l (198 mg/dl)
boolean
ID.2
Item
on treatment with metformin tablets
boolean
ID.3
Item
patients with at least 2 treated co-morbidities
boolean
ID.4
Item
established dose of metformin > 1.700 mg/day
boolean
ID.5
Item
age > 18 years old
boolean
ID.6
Item
given informed consent
boolean
ID.7
Item
patients not able to take medication orally
boolean
ID.8
Item
according to summary of product characteristics (smpc)
boolean
ID.9
Item
participating in another clinical trial 30 days prior to randomization
boolean
ID.10
Item
any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results
boolean